PaperPlayer biorxiv biochemistry

Recognition of high-risk HPV E6 oncoproteins by 14-3-3 proteins studied by interactomics and crystallography


Listen Later

Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2020.07.24.220376v1?rss=1
Authors: Gogl, G., Tugaeva, K. V., Eberling, P., Kostmann, C., Trave, G., Sluchanko, N. N.
Abstract:
In tumors induced by high-risk mucosal human papillomaviruses (hrm-HPVs), HPV E6 oncoproteins inhibit apoptotic processes and sustain cell proliferation. E6 from all hrm-HPVs harbor a C-terminal short PDZ domain-binding motif (PBM), whose phosphorylation down-regulates PDZ binding but triggers E6 binding to 14-3-3 proteins. Here we classify PBMs of E6 proteins depending on their principle ability to be phosphorylated and subsequently acquire a 14-3-3-binding motif III consensus, (pS/pT)XX-COOH. Systematic competitive fluorescence polarization measurements show that the PBMs from four selected E6 oncoproteins bind all seven human 14-3-3 isoforms with distinct, wide-ranging affinities, obeying remarkable trends assigned to 14-3-3 isoform specificity and small E6 sequence variations. We crystallized the hrm-HPV18 E6 PBM bound to 14-3-3{zeta}, revealing a 14-3-3-motif III complex at 1.9 [A] resolution. Using fluorescence polarization and crystallography, we also demonstrate that fusicoccin, a molecule that reinforces many known 14-3-3 complexes, destabilizes the 14-3-3-E6 interaction, indicating the druggability of that complex.
Copy rights belong to original authors. Visit the link for more info
...more
View all episodesView all episodes
Download on the App Store

PaperPlayer biorxiv biochemistryBy Multimodal LLC